Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging

Brain and Behavior

Volumn 4, Issue 6, 2014, Pages 841-849

  Ding, Yaling ^a   Xing, Zhen ^a   Liu, Biying ^a   Lin, Xinjian ^b   Cao, Dairong ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Brain metastases; Differential diagnosis of intracranial malignancies; High grade glioma; Primary CNS lymphoma; Susceptibility weighted imaging

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLEEDING; BLOOD VESSEL INJURY; BRAIN METASTASIS; CANCER GRADING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUSCEPTIBILITY WEIGHTED IMAGING; TUMOR DIFFERENTIATION; VASCULARIZATION; BRAIN; BRAIN TUMOR; COMPARATIVE STUDY; COMPLICATION; DIFFERENTIAL DIAGNOSIS; INTRACRANIAL HEMORRHAGES; LYMPHOMA; MIDDLE AGED; PATHOLOGY; PROCEDURES; SECONDARY; YOUNG ADULT;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOMA; HUMANS; INTRACRANIAL HEMORRHAGES; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84911418385     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.288     Document Type: Article

References (29)

1. Al-Okaili, R. N., J. Krejza, J. H. Woo, R. L. Wolf, D. M. O'Rourke, K. D. Judy, et al. 2007. Intraaxial brain masses: MR imaging-based diagnostic strategy-initial experience. Radiology 243:539-550.
2. Buhring, U., U. Herrlinger, T. Krings, R. Thiex, M. Weller, and W. Kuker. 2001. MRI features of primary central nervous system lymphomas at presentation. Neurology 57:393-396.
3. Cha, S. 2009. Neuroimaging in neuro-oncology. Neurotherapeutics 6:465-477.
4. Chaudhry, I. H., D. G. O'Donovan, P. E. Brenchley, H. Reid, and I. S. Roberts. 2001. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. Histopathology 39:409-415.
5. Cho, S. K., D. G. Na, J. W. Ryoo, H. G. Roh, C. H. Moon, H. S. Byun, et al. 2002. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J. Radiol. 3:171-179.
6. Coulon, A., F. Lafitte, K. Hoang-Xuan, N. Martin-Duverneuil, K. Mokhtari, J. Blustajn, et al. 2002. Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur. Radiol. 12:329-340.
7. Essig, M., J. R. Reichenbach, L. Schad, J. Debus, and W. A. Kaiser. 2001. High resolution MR-venography of cerebral arteriovenous malformations. Radiologe 41:288-295.
8. Frank, G., R. Ferracini, F. Spagnolli, F. Frank, G. Gaist, P. Lorenzini, et al. 1985. Primary intracranial lymphomas. Surg. Neurol. 23:3-8.
9. Gomori, J. M., R. I. Grossman, C. Yu-Ip, and T. Asakura. 1987. NMR relaxation times of blood: dependence on field strength, oxidation state, and cell integrity. J. Comput. Assist. Tomogr. 11:684-690.
10. Haacke, E. M., Y. Xu, Y. C. Cheng, and J. R. Reichenbach. 2004. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52:612-618.
11. Hakyemez, B., C. Erdogan, N. Bolca, N. Yildirim, G. Gokalp, and M. Parlak. 2006. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J. Magn. Reson. Imaging 24:817-824.
12. Helle, T. L., R. H. Britt, and T. V. Colby. 1984. Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J. Neurosurg. 60:94-103.
13. Hori, M., K. Ishigame, H. Kabasawa, H. Kumagai, S. Ikenaga, N. Shiraga, et al. 2010. Precontrast and postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasms at 1.5 T. Jpn. J. Radiol. 28:299-304.
14. Kuker, W., T. Nagele, A. Korfel, S. Heckl, E. Thiel, M. Bamberg, et al. 2005. Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients. J. Neurooncol. 72:169-177.
15. Lee, B. C., K. D. Vo, D. K. Kido, P. Mukherjee, J. Reichenbach, W. Lin, et al. 1999. MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions. Am. J. Neuroradiol. 20:1239-1242.
16. Liao, W., Y. Liu, X. Wang, X. Jiang, B. Tang, J. Fang, et al. 2009. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol. 50:217-225.
17. Liu, H. Y., X. L. Zhang, Y. P. Chen, and S. J. Qiu. 2009. Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings. Nan Fang Yi Ke Da Xue Xue Bao 29:333-336.
18. Lobel, U., J. Sedlacik, N. D. Sabin, M. Kocak, A. Broniscer, C. M. Hillenbrand, et al. 2010. Three-dimensional susceptibility-weighted imaging and two-dimensional T2*-weighted gradient-echo imaging of intratumoral hemorrhages in pediatric diffuse intrinsic pontine glioma. Neuroradiology 52:1167-1177.
19. Radbruch, A., B. Wiestler, L. Kramp, K. Lutz, P. Baumer, M. Weiler, et al. 2013. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur. J. Radiol. 82:552-556.
20. Reichenbach, J. R., R. Venkatesan, D. J. Schillinger, D. K. Kido, and E. M. Haacke. 1997. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 204:272-277.
21. Reichenbach, J. R., M. Barth, E. M. Haacke, M. Klarhofer, W. A. Kaiser, and E. Moser. 2000. High-resolution MR venography at 3.0 Tesla. J. Comput. Assist. Tomogr. 24:949-957.
22. Scatliff, J. H., W. B. Radcliffe, H. H. Pittman, and C. H. Park. 1969. Vascular structure of glioblastomas. Am. J. Roentgenol. Radium Ther. Nucl. Med. 105:795-805.
23. Scatliff, J. H., F. C. Jr Guinto, and W. B. Radcliffe. 1971. Vascular patterns in cerebral neoplasms and their differential diagnosis. Semin. Roentgenol. 6:59-69.
24. Sehgal, V., Z. Delproposto, E. M. Haacke, K. A. Tong, N. Wycliffe, D. K. Kido, et al. 2005. Clinical applications of neuroimaging with susceptibility-weighted imaging. J. Magn. Reson. Imaging 22:439-450.
25. Sehgal, V., Z. Delproposto, D. Haddar, E. M. Haacke, A. E. Sloan, L. J. Zamorano, et al. 2006. Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J. Magn. Reson. Imaging 24:41-51.
26. Sugahara, T., Y. Korogi, Y. Shigematsu, T. Hirai, I. Ikushima, L. Liang, et al. 1999. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J. Comput. Assist. Tomogr. 23:232-237.
27. Tang, Y. Z., T. C. Booth, P. Bhogal, A. Malhotra, and T. Wilhelm. 2011. Imaging of primary central nervous system lymphoma. Clin. Radiol. 66:768-777.
28. Xu, Y., and E. M. Haacke. 2006. The role of voxel aspect ratio in determining apparent vascular phase behavior in susceptibility weighted imaging. Magn. Reson. Imaging 24:155-160.
29. Zhang, D., L. B. Hu, T. D. Henning, E. M. Ravarani, L. G. Zou, X. Y. Feng, et al. 2010. MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J. Radiol. 11:269-277.